Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MRK

Medical Stocks Lead List Of New Buys By The Best Mutual Funds

The best mutual funds scooped up shares of MRK, LLY, ABBV and AMGN, while also adding retailers like WING to their holiday lists

Investors Business Daily

2 Stocks Wall Street Always Likes to Stick With

The Fed’s aggressive monetary policy stance has created widespread recession possibilities for next year. However, stable consumer spending and a hot labor market shows signs of a resilient economy. Amid this scenario, Wall Street favorites Microsoft (MSFT), and Merck & Co. (MRK) could be worth buying, considering their fundamental strength.…

StockNews.com

Is Merck & Co. Stock Worth Buying Before the End of 2022?

Healthcare company Merck & Co. (MRK) is set to acquire Imago BioSciences (IMGO) for more than $1 billion. The stock has gained more than 40% this year. However, given the macroeconomic headwinds, would it be wise to buy the stock now? Read on to find out….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Stocks Insiders Can’t Stop Buying This Month

After signs of cooling inflation, investors are hopeful that the Fed will slow its rate hikes over the coming months. With surging optimism, fundamentally strong stocks Merck (MRK), Coca-Cola (KO), and Verizon (VZ), which have seen increased insider buying, might be ideal investments now. Continue reading.

StockNews.com

4 Stocks to Buy That Have Caught Wall Street's Attention

With strong indications of slowing interest rate hikes by the Fed poised to feed the stock market rally, it could be wise to invest in Merck (MRK), AT&T (T), Mosaic (MOS), and Photronics (PLAB), which are in vogue on Wall Street. Continue reading….

StockNews.com

2 Stocks the Smart Money on Wall Street Owns the Majority Right Now

The Federal Reserve is expected to lower the pace of its rate hikes from next month. However, concerns about an economic slowdown are still evident. Hence, this might be the time to follow the smart money and buy Merck (MRK) and Yelp (YELP). Institutions own the majority of shares of…

StockNews.com

3 Stocks to Buy Before 2022 Comes to an End

With the Fed indicating that the final level of interest rates will be higher than expected, many analysts expect the economy to slip into a recession next year. Since the stock market will likely remain under pressure, investors should consider buying fundamentally strong stocks UnitedHealth Group (UNH), Merck & Co.…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

2 Stocks That Are Too Good of Buying Opportunities to Ignore

The latest CPI report shows signs of a cooling down inflation. On the other hand, the healthcare market is expected to boom amid increasing health awareness and technological advancements. Hence, we think fundamentally robust healthcare stocks Merck & Co. (MRK) and Elevance Health (ELV) could be solid investments now. Read…

StockNews.com

Hot Stocks to Buy? 3 Medical Stocks to Consider Now

The healthcare industry tends to withstand challenging macro conditions relatively well, as it enjoys inelastic demand for its products and services. And given the solid long-term prospects of the industry, it could be wise to load up fundamentally sound medical stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck (MRK)…

StockNews.com

3 Strong Buy Stocks Begging to Be Bought in Q4

The Federal Reserve announced its fourth consecutive 75-bps rate hike yesterday. As the chances of the economy falling into a recession are tightening, fundamentally strong and resilient stocks Merck & Co (MRK), Biogen (BIIB), and Kroger (KR), which are rated Strong Buy in our proprietary rating system, could be safe…

StockNews.com

This Health Care Stock Is a No-Brainer Buy for Fall

Merck & Co.’s (MRK) third-quarter financials surpassed Wall Street’s expectations. The stock is trading near its 52-week high of $101.50, and its momentum is expected to continue, considering its strong fundamentals. Given the company’s solid growth, reliable dividend payments, and the resilience of its sector against the expected economic slowdown,…

StockNews.com

What Are Whales Doing With Merck & Co

A whale with a lot of money to spend has taken a noticeably bullish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 21 strange trades.

Benzinga

Merck Offers Potential 22% Return For Bullish Option Traders

Selling this spread would generate roughly $90 in premium, which would be a 22% return in around three and a half weeks.

Investors Business Daily

3 Safe Stocks for Retirees to Buy This Fall

Market volatility is rife ahead of the Fed’s potentially aggressive rate hike in its meeting next month. With consecutive rate hikes, a recession seems unavoidable. Amid the uncertainties, we think fundamentally sound stocks Merck (MRK), Cisco Systems (CSCO), and Ryerson Holding (RYI), which pay a reliable dividend, could be safe…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

1 Medical Stock That's a Better Buy Than Its Peers

Healthcare giant (MRK) has gained more than 20% in 2022. Moreover, it pays handsome dividends to its shareholders. And its attractive valuations and robust profitability make it a better Buy than its peers. Let's discuss this in detail….

Benzinga

Looking At Merck & Co's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

StockNews.com

3 Stocks That’ll Help You Avoid Losing Money in October

With inflation showing no signs of slowing down and the Fed likely to keep raising rates, the stock market is expected to remain under pressure in the near term. And we think investing in fundamentally solid stocks Merck & Co. (MRK), Cigna (CI), and APA Corporation (APA) could help avoid…

StockNews.com

3 Dividend Stocks You Can Count on for Passive Income

The Fed’s successive rate hikes have hit household wealth. Moreover, rate hikes against a slowing economic backdrop have increased the risk of recession. Amid this, we believe stable dividend stocks Pfizer (PFE), Merck & Co. (MRK), and Valero Energy (VLO) might be ideal investments. Read more….

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

2 Stocks to Add to Your Must-Buy List in Q4

After a disappointing third-quarter performance, investors should brace themselves for an enhanced market uncertainty in the fourth quarter amid the Fed’s persistent rate hikes to tame stubborn inflation and growing recession fears. Hence, we think it could be wise to add resilient and dividend-yielding stocks Johnson & Johnson (JNJ) and…

Benzinga

Looking At Merck & Co's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 13 strange trades.

StockNews.com

3 No-Brainer Stocks to Buy if You Have Money to Spend

Raging inflation and the Fed’s commitment to bring it under control with rate hikes are raising recession worries. However, according to BofA, the market could see a rally later this year. Given the macro uncertainties, we think investors should add fundamentally solid stocks Microsoft (MSFT), Merck & Co. (MRK), and…

StockNews.com

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…

StockNews.com

3 Stocks Bullish Traders Tend to Fall in Love With

The Fed’s continued monetary policy tightening and consequent recession fears are expected to keep the stock market under pressure in the upcoming months. However, bullish traders could keep paying with fundamentally strong stocks The Coca-Cola Company (KO), AbbVie (ABBV), and Merck & Co. (MRK). Read more….

StockNews.com

2 Reliable Drug Stocks to Buy and Hold for Big-Time Gains

Persistent rate hikes by the Fed and rising odds of a recession have aggravated market turbulence and led investors to seek refuge in defensive sectors such as healthcare. Defensive stocks tend to perform well in declining markets due to the steady demand for their products. Hence, consistent dividend-yielding drug stocks…

Benzinga

What Are Whales Doing With Merck & Co

1 … 3 4 5 6

People

Dipanjan BanchurSince

722 stories

Kritika SarmahHer

714 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.